Department of Clinical Laboratory, Yixing People's Hospital, Yixing, China.
Center for Translational Medicine and Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, China.
Front Endocrinol (Lausanne). 2021 Oct 26;12:756581. doi: 10.3389/fendo.2021.756581. eCollection 2021.
Diabetes mellitus and the associated complications are metabolic diseases with high morbidity that result in poor quality of health and life. The lack of diagnostic methods for early detection results in patients losing the best treatment opportunity. Oral hypoglycemics and exogenous insulin replenishment are currently the most common therapeutic strategies, which only yield temporary glycemic control rather than curing the disease and its complications. Exosomes are nanoparticles containing bioactive molecules reflecting individual physiological status, regulating metabolism, and repairing damaged tissues. They function as biomarkers of diabetes mellitus and diabetic complications. Considering that exosomes are bioactive molecules, can be obtained from body fluid, and have cell-type specificity, in this review, we highlight the multifold effects of exosomes in the pathology and therapy of diabetes mellitus and diabetic complications.
糖尿病及其相关并发症是发病率较高的代谢性疾病,导致健康和生活质量下降。由于缺乏早期检测的诊断方法,患者错失了最佳治疗时机。目前,口服降糖药和外源性胰岛素补充是最常见的治疗策略,但只能暂时控制血糖,而不能治愈疾病及其并发症。外泌体是含有反映个体生理状态、调节代谢和修复受损组织的生物活性分子的纳米颗粒。它们可作为糖尿病及其并发症的生物标志物。鉴于外泌体是生物活性分子,可以从体液中获得,并且具有细胞类型特异性,在本综述中,我们重点介绍了外泌体在糖尿病及其并发症发病机制和治疗中的多重作用。